Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Fiserv Inc. Common Stock (FISV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Fiserv Inc. Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.3 (market cap $4.02B), while Fiserv Inc. Common Stock trades at $46.2 (market cap $24.50B). The key difference: Fiserv Inc. Common Stock is far larger — about 6.1× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Fiserv Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Fiserv Inc. Common Stock for 0 Days on average.
| EWTX | FISV | |
|---|---|---|
Market Cap | $4.02B | $24.50B |
Volume | 1,446,128 | 3,682,634 |
Sector | Health | Technology |
52-Week High | $48.35 | $126.54 |
52-Week Low | $14.89 | $44.36 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.56B | $52.29B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Fiserv Inc. Common Stock
Fiserv, Inc. is a global provider of payments and financial services technology, offering merchant acquiring, digital commerce, and financial solutions through its Merchant Solutions and Financial Solutions segments.
Read more on FISV →
